...
首页> 外文期刊>Oriental pharmacy and experimental medicine >Evaluation of aflatoxin contamination in crude medicinal plants used for the preparation of herbal medicine
【24h】

Evaluation of aflatoxin contamination in crude medicinal plants used for the preparation of herbal medicine

机译:评价用于制备草药制备的粗毒素污染

获取原文
获取原文并翻译 | 示例

摘要

The medical focus is now on phytofoods, drugs and the consumption of medicinal plants is expanding worldwide. Safety and quality of herbal preparations is of great concern. Quality determines reproducible efficacy of herbal drugs and also safety is a concern both for public and health authorities in many countries specially developing ones. The reason attributed is that many contaminants and microbes that may cause quality deterioration and directly harm to the consumers, find entry in the crude herbal materials during collection and storage. The safety of these products is partially compromised due to the microbial presence, especially toxigenic fungi. The present study was designed to investigate the microbiological quality after storage of locally sold raw medicinal plants that were supplied to different pharma units involved in the preparation of herbal and various formulations of ayurvedic drugs. Twenty samples of raw medicinal plants were stored at room temperature for a year and subjected to microbiological evaluation and found that most of the samples loaded with bacterial and fungal contents, do not comply with the FDA regulations. The presence of aflatoxin gave signals of aflatoxin producing fungi i.e. A. flavus and A. parasiticus. So, there is an urgent need of making strategy to control the microbes during pre-harvest and post-harvest procedures. This study is an attempt to emphasize the need for consistent quality assessment of crude herbal drugs for safe therapeutic products suitable for human beings. Our findings may help in instituting public health standards towards production and safety of herbal drugs worldwide.
机译:医疗重点现在正在植物植物,药物和药用植物的消费正在全球范围内扩展。草药制剂的安全和质量非常关注。质量决定了草药药物的可重复性效果,而且安全性是对许多国家的公共和卫生当局的关注,特别是发展中国家。归因的原因是许多污染物和微生物可能导致质量恶化并对消费者造成伤害,在收集和储存期间发现原油草药的进入。由于微生物存在,尤其是毒性真菌,这些产品的安全性部分受损。本研究旨在探讨储存局部销售的原药植物后的微生物质量,这些植物被提供给参与草药和各种阿育药物制剂的不同药物单位。将20种生药植物样品在室温下储存一年并进行微生物评估,发现大多数载有细菌和真菌内容物的样品,不符合FDA法规。黄曲霉毒素的存在使得黄曲霉毒素产生真菌的信号I..e.FlaVus和A.寄生。因此,迫切需要在收获预收获和收获过程中控制微生物的策略。本研究试图强调对适合人类的安全治疗产品的粗药物药物的一致质量评估。我们的调查结果可能有助于在全世界努力为制定公共卫生标准提供生产和安全。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号